EHC (STOCKS)
Encompass Health Corporation Common Stock
$107.560000
+0.310000 (+0.29%)
Prev close: $107.250000
Company Information
- Exchange
- XNYS
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- CEO
- Mark J. Tarr
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $10,688.24M
- Employees
- 29,198
- P/E (TTM)
- 19.36
- P/B (TTM)
- 4.40
- Dividend Yield
- 67.13%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
8
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$1.46 | $1.31 | +0.1488 | +11.35% |
|
Sep 2025 (Q3)
|
$1.23 | $1.21 | +0.0234 | +1.94% |
|
Jun 2025 (Q2)
|
$1.40 | $1.22 | +0.1788 | +14.64% |
|
Mar 2025 (Q1)
|
$1.37 | $1.20 | +0.1694 | +14.11% |
Financial Statements
| Revenues | $5.94B |
| Benefits Costs and Expenses | $4.98B |
| Costs And Expenses | $4.88B |
| Operating Expenses | $4.88B |
| Operating Income/Loss | $1.05B |
| Income/Loss Before Equity Method Investments | $948.70M |
| Income/Loss From Continuing Operations After Tax | $760.10M |
| Income/Loss From Continuing Operations Before Tax | $953.00M |
| Income/Loss From Discontinued Operations Net Of Tax | -$1.00M |
| Income/Loss From Equity Method Investments | $4.30M |
| Income Tax Expense/Benefit | $192.90M |
| Income Tax Expense/Benefit, Current | $170.60M |
| Income Tax Expense/Benefit, Deferred | $22.30M |
| Net Income/Loss | $759.10M |
| Net Income/Loss Attributable To Noncontrolling Interest | $192.90M |
| Net Income/Loss Attributable To Nonredeemable Noncontrolling Interest | $183.50M |
| Net Income/Loss Attributable To Parent | $566.20M |
| Net Income/Loss Attributable To Redeemable Noncontrolling Interest | $9.40M |
| Net Income/Loss Available To Common Stockholders, Basic | $564.70M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $1.50M |
| Preferred Stock Dividends And Other Adjustments | $1.50M |
| Basic Earnings Per Share | $5.62 |
| Diluted Earnings Per Share | $5.54 |
| Basic Average Shares | 100,500,000 |
| Diluted Average Shares | 102,200,000 |
| Assets | $7.09B |
| Current Assets | $905.90M |
| Accounts Receivable | $619.20M |
| Prepaid Expenses | $53.90M |
| Other Current Assets | $232.80M |
| Noncurrent Assets | $6.18B |
| Intangible Assets | $308.30M |
| Other Non-current Assets | $5.88B |
| Liabilities | $3.81B |
| Current Liabilities | $836.40M |
| Accounts Payable | $178.20M |
| Wages | $243.70M |
| Other Current Liabilities | $414.50M |
| Noncurrent Liabilities | $2.98B |
| Redeemable Noncontrolling Interest | $58.30M |
| Equity | $3.22B |
| Equity Attributable To Noncontrolling Interest | $779.30M |
| Equity Attributable To Parent | $2.44B |
| Temporary Equity | $58.30M |
| Liabilities And Equity | $7.09B |
| Net Cash Flow From Operating Activities | $1.17B |
| Net Cash Flow From Operating Activities, Continuing | $1.18B |
| Net Cash Flow From Operating Activities, Discontinued | -$1.40M |
| Net Cash Flow From Investing Activities | -$764.60M |
| Net Cash Flow From Investing Activities, Continuing | -$764.60M |
| Net Cash Flow From Financing Activities | -$431.20M |
| Net Cash Flow From Financing Activities, Continuing | -$431.20M |
| Net Cash Flow | -$21.60M |
| Net Cash Flow, Continuing | -$20.20M |
| Net Cash Flow, Discontinued | -$1.40M |
| Comprehensive Income/Loss | $759.60M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $192.90M |
| Comprehensive Income/Loss Attributable To Parent | $566.70M |
| Other Comprehensive Income/Loss | $500.00K |